Qualifications

PhD

Personal/work Web page addresses

• https://www.vaccinevalue.org

Contact

• • kaja.abbas@nagasaki-u.ac.jp
  • kaja.abbas@lshtm.ac.uk

Affiliation(s)

• School of Tropical Medicine and Global Health, Nagasaki University
• London School of Hygiene and Tropical Medicine

Background

My research area is vaccine impact modelling with a focus on estimating the health, economic, and equity impact of vaccination programmes to support evidence-based decision-making on vaccination strategies in collaboration with partners and stakeholders at the global, regional, and national levels. I have worked on impact assessment of existing and new vaccines to inform vaccine policy in varied contextual settings of low-, middle-, and high-income countries.

I hold a joint position with LSHTM and Nagasaki University. I welcome collaborations related to estimating vaccination impact in different geographic settings, and you are welcome to contact me.

Teaching

• Epidemiology and Statistics for Population Health
• Advanced Methods of Policy Analysis
• Global Health Seminar

Research

• Vaccine impact modelling
• Vaccine epidemiology and economics

The country/countries where you work currently

Global

Five MOST IMPORTANT/INTERESTING recent publications

1. Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. The Lancet Infectious Diseases, 24(5), 2024. DOI: 1016/S1473-3099(23)00810-1
2. Abbas K, Yoo KJ, Prem K, Jit M. Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study. EClinicalMedicine, 70:102524, 2024. DOI: 1016/j.eclinm.2024.102524
3. Kim C, Holm M, Frost I, Hasso-Agopsowicz M, Abbas K. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study. BMJ Global Health, 8:e011341, 2023. DOI: 1136/bmjgh-2022-011341
4. Giannini F, Cannon JW, Cadarette D, Bloom D, Moore H, Carapetis J, Abbas K. Modeling the potential health impact of prospective Strep A vaccines. NPJ Vaccines, 8(90), 2023. DOI: 1038/s41541-023-00668-0
5. Liu Y, Pearson CAB, Sandmann FG, Barnard RC, Kim JH, CMMID COVID-19 Working Group, Flasche S, Jit M, Abbas K. Dosing interval strategies for two-dose COVID-19 vaccination in 13 low- and middle-income countries of Europe: health impact modelling and benefit-risk analysis. The Lancet Regional Health – Europe, 17(100381), 2022. DOI: 1016/j.lanepe.2022.100381

 

More publications can be viewed on the ResearchMap and LSHTM pages